Global Generic Drugs Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Generic Drugs Market was valued at $465 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.5% CAGR, to an estimated market size of $637 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global generic drugs market comprises pharmaceutical products that are bioequivalent to branded medications in terms of active ingredients, dosage, strength, safety, and intended use. These products are manufactured and distributed following the expiration of patent protection or other exclusivity rights of the original innovator drug, serving as a primary mechanism for healthcare cost containment.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Generic Drugs Market in the period 2025-30:
- The upcoming patent cliff for high-revenue biologics is accelerating the transition toward biosimilars, particularly in oncology and autoimmune therapies.
- Integration of Artificial Intelligence (AI) and machine learning is optimizing drug design, bioequivalence modeling, and manufacturing efficiency to reduce time-to-market.
- A strategic shift is occurring from low-margin simple oral solids toward complex generics with high technical barriers to entry to escape price erosion.
- Rising prevalence of chronic diseases such as diabetes and cardiovascular conditions is driving sustained demand for long-term, affordable medication regimens.
- Governments and insurers are intensifying cost-containment measures, increasingly mandating generic substitution to manage escalating healthcare expenditures.
- The rapid expansion of online pharmacies and digital health platforms is improving patient access and price transparency for generic medications globally.
- Increased industry consolidation through mergers and acquisitions is helping major players enhance manufacturing capacity and navigate stringent regulatory landscapes.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Small-Molecule Generics
- Biosimilars
- Complex & Super Generics